Yahoo · Sep 8, 2026
Novartis Trial Failure Sparks Biopharma Options Frenzy
3 biopharma stocks seeing high options volume
AM
AMEX · AMS
American Shared Hospital Services
Healthcare · Medical - Care Facilities
$1.47
Down-$0.02 (-1.32%)
Updated Sep 14, 2026, 2:42 PM
SID Score
3.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 13.86M
- P/E ratio
- -6.17
- Dividend yield
- 0.00%
- 52-week range
- $1.25 – $3.11
- Volume
- 6.87K
- Avg. volume
- 9.69K
Price performance
AMS price history
1M range · 19 trading sessions · Daily adjusted prices
AMS closed at $1.47 after 19 trading sessions, down 4.87% for the selected period.
- Last close
- $1.47
- Period change
- -4.87%
- Period low
- $1.42
- Period high
- $1.55
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | $1.42 | $1.4745 | $1.42 | $1.4745 | 6.87K |
| Sep 10, 2026 | $1.47 | $1.47 | $1.42 | $1.47 | 32.5K |
| Sep 9, 2026 | $1.42 | $1.54 | $1.42 | $1.49 | 9.51K |
| Sep 8, 2026 | $1.43 | $1.44 | $1.41 | $1.42 | 5.2K |
| Sep 4, 2026 | $1.46 | $1.46 | $1.411 | $1.43 | 15.14K |
| Sep 3, 2026 | $1.44 | $1.46 | $1.4101 | $1.46 | 10.21K |
| Sep 2, 2026 | $1.49 | $1.49 | $1.44 | $1.44 | 2.56K |
| Sep 1, 2026 | $1.44 | $1.4639 | $1.44 | $1.4639 | 3.26K |
| Aug 31, 2026 | $1.44 | $1.5094 | $1.44 | $1.44 | 4.56K |
| Aug 28, 2026 | $1.4418 | $1.47 | $1.4418 | $1.47 | 2.89K |
| Aug 27, 2026 | $1.4301 | $1.49 | $1.4301 | $1.46 | 4.24K |
| Aug 26, 2026 | $1.46 | $1.51 | $1.4538 | $1.51 | 3.84K |
| Aug 25, 2026 | $1.4407 | $1.47 | $1.4407 | $1.47 | 951.42 |
| Aug 24, 2026 | $1.51 | $1.53 | $1.43 | $1.43 | 4.82K |
| Aug 21, 2026 | $1.53 | $1.535 | $1.51 | $1.51 | 4.44K |
| Aug 20, 2026 | $1.52 | $1.52 | $1.44 | $1.5115 | 26.68K |
| Aug 19, 2026 | $1.51 | $1.535 | $1.4728 | $1.53 | 25.6K |
| Aug 18, 2026 | $1.54 | $1.54 | $1.4802 | $1.51 | 19.65K |
| Aug 17, 2026 | $1.51 | $1.5563 | $1.51 | $1.55 | 12.89K |
Latest AMS news
The latest Smart Investors Daily articles mentioning AMS.
Stock researchCompany · Overview
AMS research
Overview
Company profile and research snapshot.
Company profile
American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy, and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities. The company, along with its subsidiaries, operates through the following operations: Gamma Knife, Advanced Radiation Therapy Equipment and Services, and Proton Beam Radiation Therapy Operations. It generates most of its revenue from the domestic market.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
Yahoo · Sep 7, 2026
Form 8.3
LONDON, September 07, 2026-- FORM 8.3
SeekingAlpha · Aug 13, 2026
American Shared Hospital Services (AMS) Q2 2026 Earnings Call Transcript
American Shared Hospital Services (AMS) Q2 2026 Earnings Call August 13, 2026 1:00 PM EDTCompany ParticipantsRaymond Stachowiak - Executive ChairmanCraig K.
Benzinga · Aug 13, 2026
American Shared Hospital Q2 2026 Earnings Call Transcript
American Shared Hospital (AMEX:AMS) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. This content is powered by Benzinga APIs. For comprehensive financial
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
